Skip to content

Author

N. El Jurdi

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Membranous Conjunctivitis in Acute and Chronic Graft-Versus-Host Disease: Longitudinal Ocular Outcomes.

PURPOSE To characterize longitudinal ocular surface outcomes and survival in a contemporary cohort of patients with membranous conjunctivitis (MC) after allogeneic hematopoietic cell transplantation (HCT). METHODS Retrospective review of serial ocular assessments performed on patients from baseline through 12-18 mont...

Aaron T. Zhao, N. El Jurdi, Chantal Cousineau-Krieger et al. · 0 citations
Oct 2026

Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis.

BACKGROUND Only 3%-5% of patients with cancer nationwide enroll in clinical trials. Although participation among patients with solid tumors has been well studied, data in the hematopoietic stem cell transplantation (HSCT) setting remain limited. We sought to (1) describe clinical trial participation rates by HSCT type;...

Tamryn Fowler, R. Brazauskas, Jinalben Patel et al. · 0 citations
Open access Oct 2026

Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.

It was determined that PT-Cy-mediated T cell depletion also depleted pathogen-specific TCRs, rendering PT-Cy patients more likely to lack detectable graft-derived pathogen-specific TCRs early after transplant, which was associated with an increased risk of severe infection.

S. DeWolf, S. Siegel, Joseph Schmalz et al. · 0 citations
Open access Oct 2026

Mitochondrial genetic variation as a novel predictor of graft-versus-host disease after stem-cell transplantation in myelodysplastic neoplasms

Graft-versus-host disease (GvHD) remains a major cause of morbidity and non-relapse mortality after allogeneic hematopoietic cell transplantation. Building on prior evidence implicating mitochondrial DNA (mtDNA) variation in myelodysplastic neoplasms (MDS), we investigated the prognostic impact of recipient and donor m...

Shahram Arsang-Jang, Tao Zhang, M. Rafati et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.